- Home
- CHE
CHE
Chemed Corp
as 07-25-2025 4:00pm EST
Chemed Corp purchases, operates, and divests subsidiaries engaged in diverse business activities to maximize shareholder value. Through its subsidiaries, the company operates in the following segments: VITAS and Roto-Rooter. The VITAS segment generates the majority of the firm's revenue and provides hospice and palliative care services to patients with terminal illnesses through a network of physicians, registered nurses, home health aides, social workers, and volunteers. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and related services to residential and commercial customers.
Upcoming Earnings Alert:
Get ready for potential market movements as Chemed Corp CHE prepares to release earnings report on 29 Jul 2025.
| Founded: | 1970 | Country: | United States |
| Employees: | N/A | City: | CINCINNATI |
| Market Cap: | 8.0B | IPO Year: | N/A |
| Target Price: | $596.67 | AVG Volume (30 days): | 184.7K |
| Analyst Decision: | Buy | Number of Analysts: | 3 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 20.53 | EPS Growth: | 10.48 |
| 52 Week Low/High: | $449.01 - $623.61 | Next Earning Date: | 07-29-2025 |
| Revenue: | $2,488,997,000 | Revenue Growth: | 8.52% |
| Revenue Growth (this year): | 6.2% | Revenue Growth (next year): | 6.47% |
Stock Insider Trading Activity of Chemed Corp (CHE)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| LEE SPENCER S | CHE | executive vice president | May 16 '25 | Sell | $577.99 | 1,500 | $866,985.00 | 14,627 | |
| LEE SPENCER S | CHE | executive vice president | May 7 '25 | Sell | $577.86 | 1,500 | $866,790.00 | 14,627 | |
| MCNAMARA KEVIN J | CHE | president and CEO | May 5 '25 | Sell | $576.45 | 1,500 | $864,675.00 | 101,197 |
Latest Chemed Corp News
CHE Breaking Stock News: Dive into CHE Ticker-Specific Updates for Smart Investing
Argus Research
a month ago
CHE: Raising target price to $613.00
StockStory
a month ago
5 Must-Read Analyst Questions From Chemed’s Q1 Earnings Call
StockStory
a month ago
1 Cash-Producing Stock Worth Your Attention and 2 to Brush Off
Argus Research
2 months ago
CHE: Lowering target price to $609.00
StockStory
2 months ago
Senior Health, Home Health & Hospice Stocks Q1 In Review: Chemed (NYSE:CHE) Vs Peers
StockStory
2 months ago
3 Reasons CHE is Risky and 1 Stock to Buy Instead
StockStory
2 months ago
3 Healthcare Stocks Skating on Thin Ice
Zacks
2 months ago
AMED or CHE: Which Is the Better Value Stock Right Now?
Compare CHE vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "CHE Chemed Corp - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.